Cereblon (CRBN) is a primary target of thalidomide and mediates its multiple pharmacological activities, including teratogenic and antimyeloma activities. CRBN functions as a substrate receptor of the E3 ubiquitin ligase CRL4, whose substrate specificity is modulated by thalidomide and its analogs. Although a number of CRL4CRBN substrates have recently been identified, the substrate involved in thalidomide teratogenicity is unclear. Here we show that p63 isoforms are thalidomide-dependent CRL4CRBN neosubstrates that are responsible, at least in part, for its teratogenic effects. The p53 family member p63 is associated with multiple developmental processes. ∆Np63α is essential for limb development, while TAp63α is important for cochlea development and hearing. Using a zebrafish model, we demonstrate that thalidomide exerts its teratogenic effects on pectoral fins and otic vesicles by inducing the degradation of ∆Np63α and TAp63α, respectively. These results may contribute to the invention of new thalidomide analogs lacking teratogenic activity.
p63 is a cereblon substrate involved in thalidomide teratogenicity / T. Asatsuma-Okumura, H. Ando, M. De Simone, J. Yamamoto, T. Sato, N. Shimizu, K. Asakawa, Y. Yamaguchi, T. Ito, L. Guerrini, H. Handa. - In: NATURE CHEMICAL BIOLOGY. - ISSN 1552-4469. - 15:11(2019 Nov 15), pp. 1077-1084.
Titolo: | p63 is a cereblon substrate involved in thalidomide teratogenicity |
Autori: | |
Settore Scientifico Disciplinare: | Settore BIO/11 - Biologia Molecolare |
Data di pubblicazione: | 15-nov-2019 |
Rivista: | |
Tipologia: | Article (author) |
Data ahead of print / Data di stampa: | 7-ott-2019 |
Digital Object Identifier (DOI): | http://dx.doi.org/10.1038/s41589-019-0366-7 |
Appare nelle tipologie: | 01 - Articolo su periodico |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
Nat Chem Biol Guerrini.pdf | Publisher's version/PDF | Administrator Richiedi una copia |